We are live on
!
Find out more
SP
SIH Partners Portfolio holdings
AUM
$7.58B
1-Year Est. Return
5.28%
This Fund
S&P 500
This Quarter
Est. Return
+0.43%
1 Year Est. Return
+5.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.95B
AUM Growth
+$974M
(+49%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
35.62%
Top 10 Holdings %
Top 10 Hldgs %
65.51%
Holding
315
New
184
Increased
39
Reduced
33
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$123M |
| 2 |
Stellantis
STLA
|
+$38.7M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$31.6M |
| 4 |
NetEase
NTES
|
+$28M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$263M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$115M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$108M |
| 4 |
UBS Group
UBS
|
+$101M |
| 5 |
Logitech
LOGI
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.41% |
| 2 | Financials | 5.13% |
| 3 | Healthcare | 5.02% |
| 4 | Communication Services | 1.71% |
| 5 | Materials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
226
DELISTED
SpringWorks Therapeutics
SWTX
| $204K | 0.01% |
+4,628
| New | +$213K |
|
227
Waters Corp
WAT
$36.4B
| $204K | 0.01% |
+553
| New | +$214K |
|
|
AKRO
228
DELISTED
Akero Therapeutics
AKRO
| $203K | 0.01% |
+5,018
| New | +$213K |
|
229
CALL
B2Gold
BTG
$5.16B
| $202K | 0.01% |
71,000
-39,000
| -35% | -$105K |
|
230
Alvotech
ALVO
$1.04B
| $184K | 0.01% |
+19,000
| New | +$231K |
|
231
Immunovant
IMVT
$8.23B
| $183K | 0.01% |
+10,705
| New | +$224K |
|
232
Acadia Pharmaceuticals
ACAD
$4.35B
| $179K | 0.01% |
+10,756
| New | +$195K |
|
233
BW LPG
BWLP
$3.2B
| $176K | 0.01% |
16,197
+6,197
| +62% | +$73.8K |
|
234
Adaptive Biotechnologies
ADPT
$3.61B
| $164K | 0.01% |
+22,113
| New | +$170K |
|
235
Amneal Pharmaceuticals
AMRX
$5.78B
| $164K | 0.01% |
+19,536
| New | +$163K |
|
|
FOLD
236
DELISTED
Amicus Therapeutics
FOLD
| $158K | 0.01% |
+19,364
| New | +$179K |
|
237
Weibo
WB
$1.92B
| $147K | 0.01% |
15,500
-4,700
| -23% | -$47.7K |
|
238
ImmunityBio
IBRX
$7.32B
| $139K | ﹤0.01% |
+46,017
| New | +$139K |
|
239
10x Genomics
TXG
$5.83B
| $117K | ﹤0.01% |
+13,401
| New | +$169K |
|
240
Pacific Biosciences
PACB
$422M
| $108K | ﹤0.01% |
+91,128
| New | +$140K |
|
241
MannKind Corp
MNKD
$1.22B
| $96.2K | ﹤0.01% |
+19,132
| New | +$107K |
|
242
Intellia Therapeutics
NTLA
$1.49B
| $95.3K | ﹤0.01% |
+13,406
| New | +$135K |
|
243
BioCryst Pharmaceuticals
BCRX
$2.43B
| $94.8K | ﹤0.01% |
+12,639
| New | +$102K |
|
|
BPT
244
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $84.7K | ﹤0.01% |
154,000
+119,000
| +340% | +$67.4K |
|
245
Lufax Holding
LU
$1.27B
| $81.4K | ﹤0.01% |
27,400
| – | – |
|
246
Uranium Energy
UEC
$4.9B
| $75.7K | ﹤0.01% |
+15,840
| New | +$99.3K |
|
247
Absci
ABSI
$1.28B
| $74.9K | ﹤0.01% |
+29,836
| New | +$109K |
|
248
Personalis
PSNL
$1.28B
| $70.1K | ﹤0.01% |
+19,966
| New | +$94.9K |
|
249
NexGen Energy
NXE
$6.17B
| $68.8K | ﹤0.01% |
+15,313
| New | +$90.5K |
|
250
Iovance Biotherapeutics
IOVA
$2.19B
| $68.7K | ﹤0.01% |
+20,637
| New | +$106K |
|
Similar funds
OPERF
AMH
ASN
CCM
YAM
JF
MAM
BFM
SIH Partners's Q1 2025 Portfolio in Review
As of Q1 2025, SIH Partners held 315 positions worth $2.95B, up 49% from $1.98B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
SIH Partners deployed $1.05B of net new capital in Q1 2025, opening 184 new positions and adding to 39 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $115M trimmed.
- SIH Partners's largest Q1 2025 buy was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.
- SIH Partners added most to Stellantis in Q1 2025, an estimated $38.7M increase.
- SIH Partners's biggest Q1 2025 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $115M.
- SIH Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $263M.
- SIH Partners's ten largest holdings make up 66% of its $2.95B portfolio in Q1 2025.
- SIH Partners opened 184 new positions and closed 45 in Q1 2025.
- SIH Partners's portfolio value rose 49% quarter-over-quarter to $2.95B.
Based on SIH Partners's 13F filing for Q1 2025, filed 15 May 2025.